FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lumigan (bimatoprost) filed by Allergan, resulting in changes to labeling or indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)

Snippet

SUPPL AP for LUMIGAN (BIMATOPROST)